| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/25/2008 | US20080319184 Uses of Dinucleotide Polyphosphate Derivatives |
| 12/25/2008 | US20080319175 Transthyretin Stabilization |
| 12/25/2008 | US20080319087 Use of Ambroxol for the Treatment of Rhinovirus Infections |
| 12/25/2008 | US20080319086 Deuterium-enriched salmeterol |
| 12/25/2008 | US20080319085 Titration dosing regimen for controlled release tramadol |
| 12/25/2008 | US20080319084 Wrinkling Prevention or Remedy with Adam Activity Inhibiting Substance |
| 12/25/2008 | US20080319083 Medicine for transnasal administration |
| 12/25/2008 | US20080319082 Biphenyl and Naphthyl-Phenyl Hydroxamic Acid Derivatives |
| 12/25/2008 | US20080319079 Method for Administering Formoterol Using a Nebulizer |
| 12/25/2008 | US20080319078 Triphenylethylene Compounds Useful as Selective Estrogen Receptor Modulators |
| 12/25/2008 | US20080319077 Remedy for Diabetes |
| 12/25/2008 | US20080319076 Compositions comprising creatine salts and methods of use thereof |
| 12/25/2008 | US20080319075 Polymorphic forms of nateglinide |
| 12/25/2008 | US20080319074 Glucagon Receptor Antagonists, Preparation and Therapeutic Uses |
| 12/25/2008 | US20080319073 Colonic delivery therapeutic agents for inflammatory bowel disease |
| 12/25/2008 | US20080319072 Composition and method for treating bacterial, viral, fungal diseases, inflammation and pain |
| 12/25/2008 | US20080319071 Novel Nutraceutical and Pharmaceutical Compositions and Use Thereof for the Treatment, Co-Treatment or Prevention of Inflammatory Disorders |
| 12/25/2008 | US20080319070 Sanitizing and Cleaning Composition and its Use for Sanitizing and/or Cleaning Hard Surfaces |
| 12/25/2008 | US20080319069 Moisturizing skin by contact with the product of reacting glycerol, trimethylolethane or pentaerythritol with ethylene oxide and/or 1,2-propylene oxide and reacting the product with a C8-22 fatty acid; each oxyalkylene chain contains no more than 5 units |
| 12/25/2008 | US20080319068 Novel Polymorph of Acetylsalicylic Acid, and Methods of Making and Using the Same |
| 12/25/2008 | US20080319067 Acetic acid, 6-(4-chlorophenyl-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-2-yl) ester; nontoxic; high bioavailability; side effect reduction; pharmakinetics;antiallergens; antiinflammatory agents; skin disorders; bronchodilators; asthma; psoriasis; eczema; antiarthritic agents |
| 12/25/2008 | US20080319066 Jasmonate Derivative Compounds, Pharmaceuticals Compounds and Methods of Use Thereof |
| 12/25/2008 | US20080319065 Systemic and Intrathecal Effects of a Novel Series of Phospholipase A2 Inhibitors on Hyperalgesia and Spinal Pge2 Release |
| 12/25/2008 | US20080319064 Deuterium-enriched oseltamivir |
| 12/25/2008 | US20080319063 Curing accelerator and method of making |
| 12/25/2008 | US20080319061 Process for the Preparation of an Oxaliplatin Preparation |
| 12/25/2008 | US20080319060 Composition containing vitamin c |
| 12/25/2008 | US20080319059 Caffeic Acid Derivative and Composition Containing the Same |
| 12/25/2008 | US20080319058 Skin Care Products, As Well As Foods And Beverages Containing 6-O-Pufa Ascorbic Esters |
| 12/25/2008 | US20080319057 2-[[2-[4-(3-Fluoro-benzyloxy)-3-methoxy-phenyl]-ethyl]-isobutylamino]-N-methyl-acetamide, useful in preventing neurological, psychiatric, cardiovascular, inflammatory, ophthalmic, urogenital and gastrointestinal disorders |
| 12/25/2008 | US20080319056 Butylphthalide Self-Emulsifying Drug Delivery System, Its Preparation Method and Application |
| 12/25/2008 | US20080319055 Cooling Compounds |
| 12/25/2008 | US20080319054 Treatment of Cancer |
| 12/25/2008 | US20080319052 Lipopexia Inhibitor and Food or Beverage |
| 12/25/2008 | US20080319051 Liquiritigenin and derivatives as selective estrogen receptor beta agonists |
| 12/25/2008 | US20080319050 Preparation Containing Oxidized Flavonoid Derivatives |
| 12/25/2008 | US20080319049 Compounds For the Treatment of Metabolic Disorders |
| 12/25/2008 | US20080319048 Solubilized formulation of docetaxel without tween 80 |
| 12/25/2008 | US20080319047 Novel Glucitol Derivative, Prodrug Thereof And Salt Thereof, And Therapeutic Agent Containing The Same For Diabetes |
| 12/25/2008 | US20080319046 Substituted sulfonamide-indoles |
| 12/25/2008 | US20080319045 Combination of Histone Deacetylase Inhibitors and Radiation |
| 12/25/2008 | US20080319044 Compounds and Methods of Use Thereof |
| 12/25/2008 | US20080319043 3,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor Antagonists |
| 12/25/2008 | US20080319042 Compositions and methods for treatment of liver disease |
| 12/25/2008 | US20080319041 Lofexidine enantiomers for use as a treatment for CNS disease and pathologies and its chiral synthesis |
| 12/25/2008 | US20080319040 N-Acylic Aminoacid Derivatives, Method For The Production Thereof, Pharmacological Composition And The Use In The Form Anti-Allergic, Anti-Inflammatory And Hypolipidemic Agents |
| 12/25/2008 | US20080319039 Unit dosage forms of temozolomide |
| 12/25/2008 | US20080319038 Preventative or therapeutic agent for acute renal failure |
| 12/25/2008 | US20080319037 1,2,4-triazol-1-yl bisphenyl derivatives for use in the treatment of endocrine-dependent tumors |
| 12/25/2008 | US20080319036 administering to overweight subject a pharmaceutical composition comprising a sustained release formulation of zonisamide or a pharmaceutically acceptable salt thereof, either alone or in combination with bupropion or other compound that enhances the activity of norepinephrine and/or dopamine via uptake |
| 12/25/2008 | US20080319034 Method for producing precious material for ornamental articles and precious material for ornamental articles which can be obtained in particular by means of this method |
| 12/25/2008 | US20080319033 3-{3-[5-(4-acetylphenyl)-4-methylthiazol-2-yl]-ureido}-N-tert-butylpropionamide, exhibiting phosphatidylinositol 3-kinase inhibitory activity and used for treating respiratory system disorders, such as asthma |
| 12/25/2008 | US20080319032 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 12/25/2008 | US20080319031 Novel Tyrosine Derivatives |
| 12/25/2008 | US20080319030 Sydnonimines - specific dopamine reuptake inhibitors and their use in treating dopamine related disorders |
| 12/25/2008 | US20080319028 Dicycloalkylcarbamoyl Ureas As Glucokinase Activators |
| 12/25/2008 | US20080319027 Composition and Method for Treating Fibrotic Diseases |
| 12/25/2008 | US20080319026 Substituted n-aryl pyridinones |
| 12/25/2008 | US20080319025 Therapeutic and Diagnostic Methods Dependent on CYP2A Enzymes |
| 12/25/2008 | US20080319024 Rosiglitazone Phosphate and Polymorphic Forms |
| 12/25/2008 | US20080319022 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| 12/25/2008 | US20080319021 Inhibition Of Phosphoinositide 3-Kinase Beta |
| 12/25/2008 | US20080319020 4-Oxadiazolyl-Piperidine Compounds and Use Thereof |
| 12/25/2008 | US20080319019 Therapeutic Agents |
| 12/25/2008 | US20080319018 Organic compounds |
| 12/25/2008 | US20080319017 Non-Anilinic Derivatives of Isothiazol-3(2H)-Thione 1,1-Dioxides As Liver X Receptor Modulators |
| 12/25/2008 | US20080319014 Nitroxides for Use in Treating or Preventing Diabetes |
| 12/25/2008 | US20080319013 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazole-2-ones and, 4-(substituted cycloalkylmethyl) imidazole-2-ones and related compounds |
| 12/25/2008 | US20080319012 2-Pyridyl substituted imidazoles as ALK5 and/or ALK4 inhibitors |
| 12/25/2008 | US20080319011 Protein tyrosine kinase enzyme inhibitors |
| 12/25/2008 | US20080319010 Use of Chloroquine to Treat Metabolic Syndrome |
| 12/25/2008 | US20080319009 Methylene-bridged selective androgen receptor modulators and methods of use thereof |
| 12/25/2008 | US20080319008 Compounds Having Activity in Increasing Ion Transport by Mutant-Cftr and Uses Thereof |
| 12/25/2008 | US20080319007 Deuterium-enriched montelukast |
| 12/25/2008 | US20080319006 Nebulizer Formulation |
| 12/25/2008 | US20080319005 Phenylacetamides Suitable as Protein Kinase Inhibitors |
| 12/25/2008 | US20080319004 Deuterium-enriched clopidogrel |
| 12/25/2008 | US20080319002 Xanthine Derivatives a Useful as Muscarinic Receptor Antagonists |
| 12/25/2008 | US20080319001 Cancer Treatment Using Specific 3,6,9-Substituted Acridines |
| 12/25/2008 | US20080319000 Use of 3,1IB-Cis-Dihydrotetrabenazine for the Treatment of Symptoms of Huntingtons Disease |
| 12/25/2008 | US20080318999 Tricyclic Benzimidazoles and Their Use as Metabotropic Glutamate Receptor Modulators |
| 12/25/2008 | US20080318998 Alkyloxy Substituted Thiazoloquinolines and Thiazolonaphthyridines |
| 12/25/2008 | US20080318997 Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
| 12/25/2008 | US20080318996 6-Amino(Aza)Indane Compounds Suitable for Treating Disorders that Respond to Modulation of the Dopamine D3 Receptor |
| 12/25/2008 | US20080318995 N-Substituted Indenoisoquinolines and Syntheses Thereof |
| 12/25/2008 | US20080318994 Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment |
| 12/25/2008 | US20080318993 Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment |
| 12/25/2008 | US20080318992 Method of using a pkc inhibitor to reverse prefrontal cortical declines |
| 12/25/2008 | US20080318991 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1 |
| 12/25/2008 | US20080318990 Spiroindolines as modulators of chemokine receptors |
| 12/25/2008 | US20080318989 Pyrimidine Kinase Inhibitors |
| 12/25/2008 | US20080318988 Pyrimidylaminobenzamide Derivatives For the Treatment of Neurofibromatosis |
| 12/25/2008 | US20080318987 Methods for modulating bone formation and mineralization |
| 12/25/2008 | US20080318986 Ddc Compositions |
| 12/25/2008 | US20080318985 Novel 2-Aminopyrimidinone Or 2-Aminopyridinone Derivatives and Their Use |
| 12/25/2008 | US20080318984 Compounds Having Activity in Correcting Mutant-Cftr Processing and Uses Thereof |
| 12/25/2008 | US20080318983 A2b adenosine receptor antagonists |
| 12/25/2008 | US20080318982 Pharmaceutical Combination for the Treatment of Luts |
| 12/25/2008 | US20080318981 Novel Compounds 480 |
| 12/25/2008 | US20080318980 USE OF 7-(PYRIMIDIN-4 YL)-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONES AS GSK-3BETA INHIBITORS |